Exact Mass: 469.0750660000001
Exact Mass Matches: 469.0750660000001
Found 88 metabolites which its exact mass value is equals to given mass value 469.0750660000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Dicloxacillin
C19H17Cl2N3O5S (469.0265932000001)
Dicloxacillin is only found in individuals that have used or taken this drug. It is one of the penicillins which is resistant to penicillinase. [PubChem]Dicloxacillin exerts a bactericidal action against penicillin-susceptible microorganisms during the state of active multiplication. All penicillins inhibit the biosynthesis of the bacterial cell wall. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, dicloxacillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that dicloxacillin interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CF - Beta-lactamase resistant penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
2-(a-Hydroxyethyl)thiamine diphosphate
2-Hydroxyethyl-ThPP is involved in Glycolysis, Gluconeogenesis, Alanine and aspartate matabolism, Valine, Leucine and isoleucine biosynthesis, Pyruvate metabolism, and Butanoate metabolism [Kegg: c05125] [HMDB] 2-Hydroxyethyl-ThPP is involved in Glycolysis, Gluconeogenesis, Alanine and aspartate matabolism, Valine, Leucine and isoleucine biosynthesis, Pyruvate metabolism, and Butanoate metabolism [Kegg: c05125].
(beta-1-O-[N-(2-hydroxymethyl-3-chlorophenyl)anthraniloyl]-D-glucupyranuronic acid)
C20H20ClNO10 (469.07756900000004)
(beta-1-O-[N-(2-hydroxymethyl-3-chlorophenyl)anthraniloyl]-D-glucupyranuronic acid) belongs to the family of Glucuronides. These are compounds comprising the glucuronic acid linked to another substance via a glycosidic bond.
5-Hydroxymethylflucloxacillin
C19H17ClFN3O6S (469.05105840000004)
2,4-dinitrophenyl-S-glutathione
C16H15N5O10S (469.0539610000001)
2,4-dinitrophenyl-s-glutathione is a member of the class of compounds known as oligopeptides. Oligopeptides are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. 2,4-dinitrophenyl-s-glutathione is practically insoluble (in water) and a moderately acidic compound (based on its pKa). 2,4-dinitrophenyl-s-glutathione can be found in a number of food items such as pineapple, tea, quince, and cabbage, which makes 2,4-dinitrophenyl-s-glutathione a potential biomarker for the consumption of these food products.
Thalictrine Iodide
(+)-Magnoflorine iodide (Magnoflorine iodide), an aporphine alkaloid found in Acoruscalamus, reduces the formation of C. albicans biofilm[1]. (+)-Magnoflorine iodide has anti-fungal, anti-antidiabetic and anti-oxidative activity[2]. (+)-Magnoflorine iodide (Magnoflorine iodide), an aporphine alkaloid found in Acoruscalamus, reduces the formation of C. albicans biofilm[1]. (+)-Magnoflorine iodide has anti-fungal, anti-antidiabetic and anti-oxidative activity[2].
8-Trichloromethyl-7,8-dihydropalmatine
C22H22Cl3NO4 (469.06143420000006)
narciclasine-4-O-beta-D-glucopyranoside
C20H23NO12 (469.12201980000003)
CAY10576
C22H19N3O5S2 (469.07660840000005)
Thalictrine Iodide
(+)-Magnoflorine iodide (Magnoflorine iodide), an aporphine alkaloid found in Acoruscalamus, reduces the formation of C. albicans biofilm[1]. (+)-Magnoflorine iodide has anti-fungal, anti-antidiabetic and anti-oxidative activity[2]. (+)-Magnoflorine iodide (Magnoflorine iodide), an aporphine alkaloid found in Acoruscalamus, reduces the formation of C. albicans biofilm[1]. (+)-Magnoflorine iodide has anti-fungal, anti-antidiabetic and anti-oxidative activity[2].
Dicloxacillin
C19H17Cl2N3O5S (469.0265932000001)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CF - Beta-lactamase resistant penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic CONFIDENCE standard compound; EAWAG_UCHEM_ID 3665
Cys Cys Met Asn
Cys Cys Asn Met
Cys Met Cys Asn
Cys Met Asn Cys
Cys Asn Cys Met
Cys Asn Met Cys
N1-Demethylnicergoline
Met Cys Cys Asn
Met Cys Asn Cys
Met Asn Cys Cys
Asn Cys Cys Met
Asn Cys Met Cys
Asn Met Cys Cys
3-(2-BROMO-2-ETHOXYCARBONYL-VINYL)-2-PHENYL-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
C24H24BrNO4 (469.08886040000004)
6-methoxy-3-methyl-2-[3-methyl-3-(4-nitrophenyl)triazen-1-yl]benzothiazolium methyl sulphate
[(3S,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)tetrahydrofuran-3-yl]methyl 4-chlorobenzenesulfonate
C20H18ClF2N3O4S (469.0674562000001)
b-D-Galactopyranoside,4-nitrophenyl, 2,3,4,6-tetraacetate
C20H23NO12 (469.12201980000003)
Fmoc-(R)-3-amino-4-(2,4-dichloro-phenyl)-butyric acid
C25H21Cl2NO4 (469.08475660000005)
Fmoc-(S)-3-amino-4-(3,4-dichloro-phenyl)-butyric acid
C25H21Cl2NO4 (469.08475660000005)
(6R)-3,8-dioxo-7t-(2-phenyl-acetylamino)-(6rH)-5-thia-1-aza-bicyclo[4.2.0]octane-2ξ-carboxylic acid 4-nitro-benzyl ester
C22H19N3O7S (469.09436640000007)
(4-METHYL-THIAZOL-2-YL)-PHENYL-AMINE
C20H23NO12 (469.12201980000003)
a-D-Galactopyranoside,4-nitrophenyl, 2,3,4,6-tetraacetate
C20H23NO12 (469.12201980000003)
4-nitrophenyl tetra-o-acetyl-beta-d-glucopyranoside
C20H23NO12 (469.12201980000003)
(2R,3S,4R,5R)-2-(hydroxyMethyl)-5-(6-((2-(Methylthio)ethyl)aMino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol
C16H22F3N5O4S2 (469.10652480000005)
fmoc-(r)-3-amino-4-(3,4-dichloro-phenyl)-butyric acid
C25H21Cl2NO4 (469.08475660000005)
Tris(ethylenediamine)rhodium(III) nitrate
C6H24N9O9Rh (469.07519440000004)
fmoc-(s)-3-amino-4-(2,4-dichloro-phenyl)-butyric acid
C25H21Cl2NO4 (469.08475660000005)
Ki8751
C24H18F3N3O4 (469.12493440000003)
Voruciclib
C22H19ClF3NO5 (469.0903790000001)
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents
N-(1,3-benzodioxol-5-yl)-2-[[3-(2-methoxyphenyl)-4-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]sulfanyl]acetamide
C22H19N3O5S2 (469.07660840000005)
(2s,4s,5r)-2-Isobutyl-5-(2-Thienyl)-1-[4-(Trifluoromethyl)benzoyl]pyrrolidine-2,4-Dicarboxylic Acid
C22H22F3NO5S (469.1170718000001)
(2R)-2-[(1R)-1-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl}amino)-2-oxoethyl]-5-methylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid
6-[3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolylcarbonylamino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
C19H17Cl2N3O5S (469.0265932000001)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
(2S,5S,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
C19H17Cl2N3O5S (469.0265932000001)
1-(2,3-Dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(2-nitrophenyl)sulfonylpiperazine
[2-[2-(4-chlorophenyl)sulfanylanilino]-2-oxoethyl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
C24H20ClNO5S (469.0750660000001)
[2-(2-Methylpropylcarbamoylamino)-2-oxoethyl] 3-[(3,4-difluorophenyl)sulfonylamino]benzoate
C20H21F2N3O6S (469.11190700000003)
N-(3-Methoxy-pyrazin-2-yl)-4-[3-(3-phenyl-acryloyl)-thioureido]-benzenesulfonamide
C21H19N5O4S2 (469.08784140000006)
N-(2-fluorophenyl)-2-[[7-(2-fluorophenyl)-1,3-dimethyl-2,4-dioxo-5-pyrimido[4,5-d]pyrimidinyl]thio]acetamide
C22H17F2N5O3S (469.1020116000001)
1-(3-Aminopropyl)-3-[3-[(5-bromo-2-pyridinyl)-[(4-chlorophenyl)methyl]amino]propyl]thiourea
C19H25BrClN5S (469.07024600000005)
N-(2,6-dimethoxy-4-pyrimidinyl)-4-[(4-phenyl-2-thiazolyl)amino]benzenesulfonamide
C21H19N5O4S2 (469.08784140000006)
(2S)-2-azaniumyl-5-{[(2R)-1-[(carboxylatomethyl)amino]-1-oxo-3-{[(2-phenylethyl)carbamothioyl]sulfanyl}propan-2-yl]amino}-5-oxopentanoate
[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 3-fluorobenzoate
C17H17FN5O8P (469.07987440000005)
[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 4-fluorobenzoate
C17H17FN5O8P (469.07987440000005)
[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 2-fluorobenzoate
C17H17FN5O8P (469.07987440000005)
2-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-2-oxoethanesulfonic acid
Inauhzin
Inauhzin is a dual SirT1/IMPDH2 inhibitor, and acts as an activator p53, used in the research of cancer.
(2s,3r,4s)-4-{[(2r,3s,5s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h,3h,4h,4ah,9h-[1,3]dioxolo[4,5-j]phenanthridine-2,3,6,7-tetrol
C20H23NO12 (469.12201980000003)
3,4,10,11-tetramethoxy-5-(trichloromethyl)-7,8-dihydro-5h-6-azatetraphene
C22H22Cl3NO4 (469.06143420000006)
17-hydroxy-11-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene-9,10-dione
(7s,9r)-12-bromo-6-hydroxy-4-(3h-imidazol-4-ylmethyl)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one
3,4,5-trihydroxy-2-({7,13,14-trihydroxy-3,10-dioxo-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4(16),5,7,11,13-hexaen-6-yl}oxy)benzenecarboximidic acid
17-hydroxy-11-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene-9,10-dione
(5s)-3,4,10,11-tetramethoxy-5-(trichloromethyl)-7,8-dihydro-5h-6-azatetraphene
C22H22Cl3NO4 (469.06143420000006)
(2s,3r,4s,4ar)-4-{[(2r,3s,4r,5r,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-2h,3h,4h,4ah,9h-[1,3]dioxolo[4,5-j]phenanthridine-2,3,6,7-tetrol
C20H23NO12 (469.12201980000003)
(2r,3r,4s,4ar)-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h,3h,4h,4ah,9h-[1,3]dioxolo[4,5-j]phenanthridine-3,4,6,7-tetrol
C20H23NO12 (469.12201980000003)
2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h,3h,4h,4ah,9h-[1,3]dioxolo[4,5-j]phenanthridine-3,4,6,7-tetrol
C20H23NO12 (469.12201980000003)
[(1e)-2-{2-[(3,4-dihydroxyphenyl)(hydroxy)methyl]-2h-1,3-benzodioxol-5-yl}ethenyl]oxysulfonic acid; dimethylguanidine
C19H23N3O9S (469.1154948000001)
4-{[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-2h,3h,4h,4ah,9h-[1,3]dioxolo[4,5-j]phenanthridine-2,3,6,7-tetrol
C20H23NO12 (469.12201980000003)